Design and monitoring of photostability systems for amlodipine dosage forms.
Photostability of amlodipine (AML) has been monitored in several pharmaceutical inclusion systems characterized by plurimolecular aggregation of the drug and excipients with high molecular weight. Several formulations including cyclodextrins, liposomes and microspheres have been prepared and characterized. The photodegradation process has been monitored according to the conditions suggested by the ICH Guideline for photostability testing, by using a light cabinet equipped with a Xenon lamp and monitored by spectrophotometry. The formulations herein tested have been found to be able to considerably increase drug stability, when compared with usual pharmaceutical forms. The residual concentration detected in the inclusion complexes with cyclodextrins and liposomes was 90 and 77%, respectively, while a very good value of 97% was found for microspheres, after a radiant exposure of 11,340 kJm(-2).
Ragno
G
G
Dept. Scienze Farmaceutiche, Università della Calabria, 87036 Arcavacata di Rende (CS), Italy. ragno@unical.it
Cione
E
E
Garofalo
A
A
Genchi
G
G
Ioele
G
G
Risoli
A
A
Spagnoletta
A
A
D017311:Amlodipine / Q000737:chemistry / Q000528:radiation effects*; D003505:Cyclodextrins / Q000737:chemistry / Q000528:radiation effects; D015195:Drug Design; D004355:Drug Stability; D008081:Liposomes / Q000737:chemistry / Q000528:radiation effects; D008863:Microspheres; D010777:Photochemistry; D014466:Ultraviolet Rays
D003505:Cyclodextrins; D008081:Liposomes; D017311:Amlodipine